(Q46256864)

English

Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18996114

Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18996114

extracellular matrix

0 references

1 reference

based on heuristic

inferred from title

author name string

Ulrika W Nilsson

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18996114

Jill A Jönsson

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18996114

Charlotta Dabrosin

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18996114

language of work or name

0 references

publication date

28 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18996114

Experimental Cell Research

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18996114

315

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18996114

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18996114

1-9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18996114

The transforming growth factor-beta family

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

TGF-beta signaling: positive and negative effects on tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Transforming growth factor-beta facilitates breast carcinoma metastasis by promoting tumor cell survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Determination of TGFbeta1 protein level in human primary breast cancers and its relationship with survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Regulation of matrix biology by matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Emerging roles of proteases in tumour suppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

The tumor microenvironment: a potential arbitrator of the tumor suppressive and promoting actions of TGFbeta

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Assessment of vascularity in histological sections: effects of methodology and value as an index of angiogenesis in breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Tamoxifen induces TGF-beta 1 activity and apoptosis of human MCF-7 breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.10.015

7 January 2021

Identifiers

10.1016/J.YEXCR.2008.10.015

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18996114

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18996114

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46256864&oldid=2102286268"